9 Tips for Avoiding Tax Season Cyber Scams 
UK Consumer Confidence Weakens Amid Middle East Conflict and Rising Living Costs 
Merck's $6 Billion Bid for Terns Pharma Signals Bold Oncology Push 
Estée Lauder Sues Jo Malone Over Trademark Dispute Involving Zara 
FDA Rejects Review of Moderna’s Flu Vaccine Application, Shares Slide 
Novo Nordisk Warns of Profit Decline as Wegovy Faces U.S. Price Pressure and Rising Competition 
Oil Prices Climb as Iran Reviews U.S. Peace Proposal Amid Middle East Tensions 
Japan Eyes Oil Futures Intervention to Stabilize Yen Amid Middle East Crisis 
Sanofi Gains China Approval for Myqorzo and Redemplo, Strengthening Rare Disease Portfolio 
Federal Judge Orders Refund of Trump’s Emergency Tariffs, Potentially Returning Up to $182 Billion 
DOJ Antitrust Chief Rejects Political Fast-Track for Paramount-Skydance Deal 
Merck Raises Growth Outlook, Targets $70 Billion Revenue From New Drugs by Mid-2030s 
CK Hutchison's Panama Ports Dispute Escalates as Arbitration Claims Surpass $2 Billion 
Australia-EU Free Trade Deal Signed After Years of Negotiations 
Gold Prices Climb as Middle East Ceasefire Talks Stir Market Optimism 
OpenAI Pulls the Plug on Sora, Ending $1 Billion Disney Partnership 
Johnson & Johnson offered $8.9 billion to settle years-old lawsuits claiming that its talcum powder products caused cancer.
The New Jersey-based pharmaceutical giant described their proposal, which still needs a bankruptcy court’s approval, as an equitable and efficient resolution to all claims arising from cosmetic talc litigation.
If approved by the bankruptcy court and a majority of the claimants, the $8.9 billion deal would rank alongside those reached by cigarette corporations and opioid producers as one of the largest product liability settlements ever in the US
Thousands of claims have been filed against J&J because of talcum powder that may have contained traces of asbestos and was linked to ovarian cancer.
The company has never acknowledged wrongdoing, but as of May 2020, it no longer sells its talc-based baby powder in the US and Canada.
The $8.9 billion would be paid to the tens of thousands of claimants over 25 years through a J&J subsidiary, LTL Management LLC, which was set up to address the claims and has filed for bankruptcy protection.
A previous settlement involving LTL was rejected by an appellate court.
